Literature DB >> 24676717

Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer.

Moonmoon Deb1, Swayamsiddha Kar, Dipta Sengupta, Arunima Shilpi, Sabnam Parbin, Sandip K Rath, Vedang A Londhe, Samir Kumar Patra.   

Abstract

The dynamic nature of chromatin and its myriad modifications play a crucial role in gene regulation (expression and repression) during development, cellular survival, homeostasis, ageing, and apoptosis/death. Histone 3 lysine 4 methylation (H3K4 methylation) catalyzed by H3K4 specific histone methyltransferases is one of the more critical chromatin modifications that is generally associated with gene activation. Additionally, the deposition of H3 variant(s) in conjunction with H3K4 methylation generates an intricately reliable epigenetic regulatory circuit that guides transcriptional activity in normal development and homeostasis. Consequently, alterations in this epigenetic circuit may trigger disease development. The mechanistic relationship between H3 variant deposition and H3K4 methylation during normal development has remained foggy. However, recent investigations in the field of chromatin dynamics in various model organisms, tumors, cancer tissues, and cell lines cultured without and with therapeutic agents, as well as from model reconstituted chromatins reveal that there may be different subsets of chromatin assemblage with specific patterns of histone replacement executing similar functions. In this light, we attempt to explain the intricate control system that maintains chromatin structure and dynamics during normal development as well as during tumor development and cancer progression in this review. Our focus is to highlight the contribution of H3K4 methylation-histone variant crosstalk in regulating chromatin architecture and subsequently its function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676717     DOI: 10.1007/s00018-014-1605-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  174 in total

Review 1.  Integrin-epigenetics: a system with imperative impact on cancer.

Authors:  Moonmoon Deb; Dipta Sengupta; Samir Kumar Patra
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 2.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

3.  hDOT1L links histone methylation to leukemogenesis.

Authors:  Yuki Okada; Qin Feng; Yihui Lin; Qi Jiang; Yaqiang Li; Vernon M Coffield; Lishan Su; Guoliang Xu; Yi Zhang
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

4.  Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes.

Authors:  Sandra B Hake; Benjamin A Garcia; Monika Kauer; Stephen P Baker; Jeffrey Shabanowitz; Donald F Hunt; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

5.  Expression patterns and post-translational modifications associated with mammalian histone H3 variants.

Authors:  Sandra B Hake; Benjamin A Garcia; Elizabeth M Duncan; Monika Kauer; Graham Dellaire; Jeffrey Shabanowitz; David P Bazett-Jones; C David Allis; Donald F Hunt
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

6.  Monomethyl histone H3 lysine 4 as an epigenetic mark for silenced euchromatin in Chlamydomonas.

Authors:  Karin van Dijk; Katherine E Marley; Byeong-ryool Jeong; Jianping Xu; Jennifer Hesson; Ronald L Cerny; Jakob H Waterborg; Heriberto Cerutti
Journal:  Plant Cell       Date:  2005-08-12       Impact factor: 11.277

Review 7.  MLL translocations, histone modifications and leukaemia stem-cell development.

Authors:  Andrei V Krivtsov; Scott A Armstrong
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery.

Authors:  Chun-Ming Wong; Carmen Chak-Lui Wong; Yeung-Lam Ng; Sandy Leung-Kuen Au; Frankie Chi-Fat Ko; Irene Oi-Lin Ng
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

9.  Premitotic assembly of human CENPs -T and -W switches centromeric chromatin to a mitotic state.

Authors:  Lisa Prendergast; Chelly van Vuuren; Agnieszka Kaczmarczyk; Volker Doering; Daniela Hellwig; Nadine Quinn; Christian Hoischen; Stephan Diekmann; Kevin F Sullivan
Journal:  PLoS Biol       Date:  2011-06-14       Impact factor: 8.029

10.  A Polycomb response element in the Ubx gene that determines an epigenetically inherited state of repression.

Authors:  C S Chan; L Rastelli; V Pirrotta
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

View more
  17 in total

1.  Paternal H3K4 methylation is required for minor zygotic gene activation and early mouse embryonic development.

Authors:  Keisuke Aoshima; Erina Inoue; Hirofumi Sawa; Yuki Okada
Journal:  EMBO Rep       Date:  2015-04-29       Impact factor: 8.807

2.  H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.

Authors:  Menghan Zhou; Yiping Li; Shaofeng Lin; Yanping Chen; Yanyan Qian; Zhujiang Zhao; Hong Fan
Journal:  Dig Dis Sci       Date:  2019-02-20       Impact factor: 3.199

3.  The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.

Authors:  Alex J Gooding; Kimberly A Parker; Saba Valadkhan; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-10

4.  The expression and significance of histone lysine methylation in endometrial cancer.

Authors:  Qing Li; Nan Jia; Xiang Tao; Keqin Hua; Weiwei Feng
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

5.  Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.

Authors:  John R Horton; Xu Liu; Molly Gale; Lizhen Wu; John R Shanks; Xing Zhang; Philip J Webber; Joshua S K Bell; Stephen C Kales; Bryan T Mott; Ganesha Rai; Daniel J Jansen; Mark J Henderson; Daniel J Urban; Matthew D Hall; Anton Simeonov; David J Maloney; Margaret A Johns; Haian Fu; Ajit Jadhav; Paula M Vertino; Qin Yan; Xiaodong Cheng
Journal:  Cell Chem Biol       Date:  2016-07-14       Impact factor: 8.116

Review 6.  Understanding the genetic liability to schizophrenia through the neuroepigenome.

Authors:  John F Fullard; Tobias B Halene; Claudia Giambartolomei; Vahram Haroutunian; Schahram Akbarian; Panos Roussos
Journal:  Schizophr Res       Date:  2016-01-27       Impact factor: 4.939

7.  Native internally calibrated chromatin immunoprecipitation for quantitative studies of histone post-translational modifications.

Authors:  Adrian T Grzybowski; Rohan N Shah; William F Richter; Alexander J Ruthenburg
Journal:  Nat Protoc       Date:  2019-11-13       Impact factor: 13.491

8.  Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer.

Authors:  Swayamsiddha Kar; Dipta Sengupta; Moonmoon Deb; Arunima Shilpi; Sabnam Parbin; Sandip Kumar Rath; Nibedita Pradhan; Madhumita Rakshit; Samir Kumar Patra
Journal:  Clin Epigenetics       Date:  2014-10-13       Impact factor: 6.551

Review 9.  Epigenetics: A key paradigm in reproductive health.

Authors:  Neha Bunkar; Neelam Pathak; Nirmal Kumar Lohiya; Pradyumna Kumar Mishra
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

10.  Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Yuanyuan Chen; Shengsheng Yang; Jiewei Hu; Chaoqin Yu; Miaoxia He; Zailong Cai
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.